• 1
    Kadowaki, T.,Yamauchi, T., and Kubota, N. ( 2008) The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS. Lett. 582, 7480.
  • 2
    Kadowaki, T.,Yamauchi, T.,Kubota, N.,Hara, K.,Ueki, K., and Tobe, K. ( 2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116, 17841792.
  • 3
    Kadowaki, T. and Yamauchi, T. ( 2005) Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439451.
  • 4
    Méndez-Sánchez, N.,Chavez-Tapia, N. C.,Zamora-Valdés, D., and Uribe, M. ( 2006) Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver disease. Mini. Rev. Med. Chem. 6, 651656.
  • 5
    Yan, E.,Durazo, F.,Tong, M., and Hong K. ( 2007) Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. Nutr. Rev. 65, 376384.
  • 6
    Xu, A.,Wang, Y.,Keshaw, H.,Xu, L. Y.,Lam, K. S., and Cooper, G. J. ( 2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112, 91100.
  • 7
    You M.,Considine, R. V.,Leone, T. C.,Kelly, D. P., and Crabb, D. W. ( 2005) Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 42, 568577.
  • 8
    Thakur, V.,Pritchard, M. T.,McMullen, M. R., and Nagy, L. E. ( 2006) Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding. Am. J. Physiol. Gastrointest. Liver. Physiol. 290, G998G1007.
  • 9
    Chen, X.,Sebastian, B. M., and Nagy, L. E. ( 2007) Chronic ethanol feeding to rats decreases adiponectin secretion by subcutaneous adipocytes. Am. J. Physiol. Endocrinol. Metab. 292, E621E628.
  • 10
    Song, Z.,Zhou, Z.,Deaciuc, I.,Chen, T., and McClain, C. J. ( 2008) Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease. Hepatology 47, 867879.
  • 11
    Esfandiari, F.,You, M.,Villanueva, J. A.,Wong, D. H.,French, S. W., and Halsted, C. H. ( 2007) S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet. Alcohol. Clin. Exp. Res. 31, 12311239.
  • 12
    Baur, J. A. and Sinclair, D. A. ( 2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug. Discov. 5, 493506.
  • 13
    Hug, C.,Wang, J.,Ahmad, N. S.,Bogan, J. S.,Tsao, T. S., and Lodish, H. F. ( 2004) T-cadherin is a receptor for hexameric and high-molecular-weight forms ofAcrp30/adiponectin. Proc. Natl. Acad. Sci. USA 101, 1030810313.
  • 14
    Ajmo, JM.,Liang, X.,Rogers, C. Q., and You, M. ( 2008) Role of hepatic adiponectin receptor 2 in the protective action of dietary saturated fatty acids against alcoholic liver steatosis in mice. Alcohol Clin. Exp. Res. 32S, 39A.
  • 15
    Shklyaev, S.,Aslanidi, G.,Tennant, M.,Prima, V.,Kohlbrenner, E.,Kroutov, V.,Campbell-Thompson, M.,Crawford, J.,Shek, E. W.,Scarpace, P. J., and Zolotukhin, S. ( 2003) Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc. Natl. Acad. Sci. USA 100, 1421714222.
  • 16
    Yamauchi.T.,Nio.Y.,Maki.T.,Kobayashi, M.,Takazawa, T.,Iwabu.M.,Okada-Iwabu, M.,Kawamoto, S.,Kubota, N.,Kubota, T.,Ito, Y.,Kamon, J.,Tsuchida.A.,Kumagai, K.,Kozono, H.,Hada, Y.,Ogata, H.,Tokuyama, K.,Tsunoda M,Ide T,Murakami K,Awazawa M,Takamoto I,Froguel P,Hara K,Tobe, K.,Nagai, R.,Ueki, K., and Kadowaki, T. ( 2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332339.
  • 17
    Yamauchi, T.,Kamon, J.,Ito, Y.,Tsuchida, A.,Yokomizo, T.,Kita, S.,Sugiyama, T.,Miyagishi, M.,Hara, K.,Tsunoda, M.,Murakami, K.,Ohteki, T.,Uchida, S.,Takekawa, S.,Waki, H.,Tsuno, N. H.,Shibata, Y.,Terauchi, Y.,Froguel, P.,Tobe, K.,Koyasu, S.,Taira, K.,Kitamura, T.,Shimizu, T.,Nagai, R., and Kadowaki, T. ( 2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762769.
  • 18
    Mao, X.,Kikani, C. K.,Riojas, R. A.,Langlais, P.,Wang, L.,Ramos, F. J.,Fang, Q.,Christ-Roberts, C. Y.,Hong, J. Y.,Kim, R. Y.,Liu, F., and Dong, L. Q. ( 2006) APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell. Biol. 8, 516523.
  • 19
    Misra, P. ( 2008) AMP activated protein kinase: a next generation target for total metabolic control. Expert. Opin. Ther. Targets.2008 12, 91100.
  • 20
    Browning, J. D. and Horton, J. D. ( 2004) Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114, 14752.
  • 21
    You, M.,Matsumoto, M.,Pacold, C. M.,Cho, W. K., and Crabb, D. W. ( 2004) The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 127, 17981808.
  • 22
    García-Villafranca, J.,Guillén, A., and Castro, J. ( 2008) Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver. Biochimie 90, 460466.
  • 23
    Tomita, K.,Tamiya, G.,Ando, S.,Kitamura, N.,Koizumi, H.,Kato, S.,Horie, Y.,Kaneko, T.,Azuma, T.,Nagata, H.,Ishii, H., and Hibi, T. ( 2005) AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats. Alcohol Clin. Exp. Res. 29, 240S245S.
  • 24
    Ki, S. H.,Choi, J. H.,Kim, C. W.,Kim, S. G. ( 2007) Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity. Chem. Biol. Interact. 169, 8090.
  • 25
    Bergheim, I.,Guo, L.,Davis, M. A.,Lambert, J. C.,Beier, J. I.,Duveau, I.,Luyendyk, J. P.,Roth, R. A.,Arteel, G. E. ( 2006) Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1. Gastroenterology 130, 20992112.
  • 26
    Ji, C.,Chan, C., and Kaplowitz, N. ( 2006) Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J. Hepatol. 45, 717724.
  • 27
    You, M.,Fischer, M.,Deeg, M. A., and Crabb, D. W. ( 2002) Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J. Biol. Chem. 277, 2934229347.
  • 28
    Ji, C. and Kaplowitz, N. ( 2003) Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124, 14881499.
  • 29
    Esfandiari, F.,Villanueva, J. A.,Wong, D. H.,French, S. W., and Halsted, C. H. ( 2005) Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G54G63.
  • 30
    Rodgers, J. T.,Lerin, C.,Gerhart-Hines, Z., and Puigserver, P. ( 2008) Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett. 582, 4653.
  • 31
    You, M.,Liang, X.,Ajmo, J. M., and Ness, G. C. ( 2008) Involvement of Mammalian Sirtuin 1 in the Action of Ethanol in the Liver. Am. J. Physiol. Gastrointest. Liver. Physiol. 370, 4448.
  • 32
    You, M.,Cao, Q.,Liang, X.,Ajmo, J. M., and Ness, G. C. ( 2008) Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice. J. Nutr. 138, 497501.
  • 33
    Lieber, C. S.,Leo, M. A.,Wang, X., and Decarli, L. M. ( 2008) Effect of chronic alcohol consumption on hepatic SIRT1 and PGC-1alpha in rats. Biochem. Biophys. Res. Commun. 370, 4448.
  • 34
    Lieber, C. S.,Leo, M. A.,Wang, X.,Decarli, L. M. ( 2008) Alcohol alters hepatic FoxO1, p53, and mitochondrial SIRT5 deacetylation function. Biochem. Biophys. Res. Commun. 373, 246252.
  • 35
    Wu, A.,Ying, Z., and Gomez-Pinilla, F. ( 2006) Oxidative stress modulates Sir2alpha in rat hippocampus and cerebral cortex. Eur. J. Neurosci. 23, 25732580.
  • 36
    Fulco, M.,Cen, Y.,Zhao, P.,Hoffman, E. P.,McBurney, M. W.,Sauve, A. A., and Sartorelli, V. ( 2008) Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell. 14, 661673.
  • 37
    Hou, X.,Xu, S.,Maitland-Toolan, K. A.,Sato, K.,Jiang, B.,Ido, Y.,Lan, F.,Walsh, K.,Wierzbicki, M.,Verbeuren, T. J., and Cohen, R. A. ( 2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 283, 2001520026.
  • 38
    Civitarese.A. E.,Carling, S.,Heilbronn, L. K.,Hulver, M. H.,Ukropcova, B.,Deutsch, W. A.,Smith, S. R., and Ravussin, E. ( 2007) Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 4, e76.
  • 39
    Ajmo, J. M.,Liang, X.,Rogers, C. Q.,Murr, M. M.,You, M. ( 2008) Adiponectin normalizes LPS-and acetate-stimulated TNFα production in liver Kupffer cells through regulation of AMPK and SIRT1 signaling. Alcohol Clin. Exp. Res. 32S, 41A.
  • 40
    Jay, M. A. and Ren, J. ( 2007) Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Curr. Diabetes Rev. 3, 3339.
  • 41
    Galli, A.,Pinaire, J.,Fischer, M.,Dorris, R., and Crabb, D. W. ( 2001) The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J. Biol. Chem. 276, 6875.
  • 42
    Fischer, M.,You, M.,Matsumoto, M.,Crabb, D. W. ( 2003) Peroxisome proliferator-activated receptor alpha (PPARα) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J. Biol. Chem. 278, 2799728004.
  • 43
    Nakajima.T.,Kamijo, Y.,Tanaka, N.,Sugiyama, E.,Tanaka, E.,Kiyosawa, K.,Fukushima, Y.,Peters, J. M.,Gonzalez, F. J., and Aoyama, T. ( 2004) Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology 40, 972980.
  • 44
    Nanji, A. A.,Dannenberg, A. J.,Jokelainen, K., and Bass, N. M. ( 2004) Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. J. Pharmacol. Exp. Ther. 310, 417424.
  • 45
    Bouskila, M.,Pajvani, U. B., and Scherer, P. E. ( 2005) Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity? Int. J. Obes. (London) 29, S17S23.
  • 46
    Wang, Y.,Lam, K. S.,Yau, M. H., and Xu, A. ( 2008) Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem. J. 409, 623633.
  • 47
    Qiao, L. and Shao, J. ( 2006) SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J. Biol. Chem. 281, 3991539924.
  • 48
    Qiang, L.,Wang, H., and Farmer, S. R. ( 2007) Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha. Mol. Cell. Biol. 281, 3991539924.
  • 49
    Enomoto, N.,Takei, Y.,Hirose, M.,Konno, A.,Shibuya, T.,Matsuyama, S.,Suzuki, S.,Kitamura, K. I., and Sato, N. ( 2003) Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone. J Pharmacol. Exp. Ther. 306, 846854.
  • 50
    Tomita, K.,Azuma.T.,Kitamura, N.,Nishida, J.,Tamiya, G.,Oka, A.,Inokuchi, S.,Nishimura, T.,Suematsu, M.,Ishii, H. ( 2004) Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology 126, 873885.
  • 51
    Ohata, M.,Suzuki, H.,Sakamoto, K.,Hashimoto, K.,Nakajima, H.,Yamauchi, M.,Hokkyo, K.,Yamada, H., and Toda, G. ( 2004) Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor-alpha. Alcohol Clin. Exp. Res. 28, 139S144S.
  • 52
    Picard, F.,Kurtev, M.,Chung, N.,Topark-Ngarm, A.,Senawong, T.,Machado De Oliveira, R.,Leid, M.,McBurney, M. W.,Guarente, L. ( 2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771776.
  • 53
    Park, P. H.,Thakur, V.,Pritchard, M. T.,McMullen, M. R., and Nagy, L. E. ( 2006) Regulation of Kupffer cell activity during chronic ethanol exposure: role of adiponectin. J. Gastroenterol. Hepatol. 21: S30S33.
  • 54
    Huang, H.,Park, P. H.,McMullen, M. R., and Nagy, L. E. ( 2008) Mechanisms for the anti-inflammatory effects of adiponectin in macrophages. J. Gastroenterol. Hepatol. 23: S50S53.
  • 55
    Abdelmohsen, K.,Pullmann, R.Jr.,Lal, A.,Kim, H. H.,Galban, S.,Yang, X.,Blethrow, J. D.,Walker, M.,Shubert, J.,Gillespie, D. A.,Furneaux, H., and Gorospe, M. ( 2007) Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell. 25: 543557.
  • 56
    Steinberg, G. R.,Michell, B. J.,van Denderen, B. J.,Watt, M. J.,Carey, A. L.,Fam, B. C.,Andrikopoulos, S.,Proietto, J.,Görgün, C. Z.,Carling, D.,Hotamisligil, G. S.,Febbraio, M. A.,Kay, T. W., and Kemp, B. E. ( 2006) Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell. Metab. 4: 465474.
  • 57
    Lawler, J. F.Jr.,Yin, M.,Diehl, A. M.,Roberts, E., and Chatterjee, S. ( 1998) Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J Biol. Chem. 273: 50535059.